Cancer Drug Nilotinib Shows Promise for Parkinson ' s Patients

MONDAY, Dec. 16, 2019 -- A drug used to fight chronic myeloid leukemia might also relieve symptoms of Parkinson ' s disease, a new study finds. In a phase 2 clinical trial, researchers found that the drug nilotinib (brand name: Tasigna) increased...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news